Elevated Plasma Stromal-Cell-Derived Factor-1 Protein Levels Correlate with Severity in Patients with Community-Acquired Pneumonia

Figure 1

Levels of plasma (a) stromal-cell-derived factor-1 (SDF-1), (b) WBC counts, and (c) CRP levels in control subjects, and patients with community-acquired pneumonia (CAP) before and after treatment. The plasma SDF-1 level, WBC counts, and CRP levels were significantly elevated in patients with CAP before they received treatment compared to the controls and significantly decreased in CAP patients after having received treatment ().

(a)

(b)

(c)